19-41687105-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001291485.2(CEACAM7):c.181A>T(p.Asn61Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,613,992 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001291485.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEACAM7 | ENST00000401731.6 | c.181A>T | p.Asn61Tyr | missense_variant | Exon 2 of 5 | 2 | NM_001291485.2 | ENSP00000385932.1 | ||
CEACAM7 | ENST00000006724.7 | c.181A>T | p.Asn61Tyr | missense_variant | Exon 2 of 5 | 1 | ENSP00000006724.3 | |||
CEACAM7 | ENST00000602225.1 | c.181A>T | p.Asn61Tyr | missense_variant | Exon 2 of 3 | 1 | ENSP00000469597.1 | |||
CEACAM7 | ENST00000599715.1 | n.277A>T | non_coding_transcript_exon_variant | Exon 3 of 4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152124Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251458Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135896
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461868Hom.: 1 Cov.: 34 AF XY: 0.0000261 AC XY: 19AN XY: 727240
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74290
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.181A>T (p.N61Y) alteration is located in exon 2 (coding exon 2) of the CEACAM7 gene. This alteration results from a A to T substitution at nucleotide position 181, causing the asparagine (N) at amino acid position 61 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at